Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Meningeal Carcinomatosis 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Monocytic, Acute 1Leukemia, Hairy Cell 1Hematopoietic and Lymphatic System Neoplasm 1Glioma 1Glioblastoma 1Germinoma 1Down Syndrome 1Diabetes Insipidus 1Astrocytoma 1

Interventions

Specimen Handling 4Interviews as Topic 2merphos 1axatilimab 1X-Rays 1Tacrolimus 1Stem Cell Transplantation 1Spinal Puncture 1Resistance Training 1Psychotherapy 1Psilocybin 1Phantoms, Imaging 1Organizational Objectives 1Mycophenolic Acid 1Methotrexate 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1Cytarabine 1Cyclophosphamide 1BNT162 Vaccine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hematopoietic and Lymphatic System Neoplasm × Spinal Puncture × Clear all
NCT06895473 2026-01-30

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

OHSU Knight Cancer Institute

Phase 2 Recruiting
26 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡